Ancora Advisors, LLC Red Hill Biopharma Ltd. Transaction History

Ancora Advisors, LLC

  • $4.06 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.5 - $523.8 $41,024 - $43 Million
82,048 Added 100.0%
164,096 $82,000
Q1 2022

May 16, 2022
BUY
$1.65 - $3.12 $135,379 - $255,989
82,048 New
82,048 $207,000
Q1 2022

May 13, 2022
SELL
$1.65 - $3.12 $139,218 - $263,250
-84,375 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$2.31 - $5.85 $108,281 - $274,218
46,875 Added 125.0%
84,375 $218,000
Q3 2021

Nov 15, 2021
BUY
$4.55 - $10.36 $170,625 - $388,500
37,500 New
37,500 $172,000

Others Institutions Holding RDHL

# of Institutions
2
Shares Held
40.4K
Call Options Held
0
Put Options Held
0
View Full List

About RedHill Biopharma Ltd.

RDHL Quotes by TradingView
  • Ticker RDHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 63,823,500
  • Market Cap $465M
  • Description
  • RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...
More about RDHL
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email